XJPX7716
Market cap1.37bUSD
Jan 17, Last price
2,544.00JPY
1D
0.79%
1Q
-2.08%
Jan 2017
68.85%
Name
Nakanishi Inc
Chart & Performance
Profile
Nakanishi Inc. manufactures and sells dental, industrial, and medical products worldwide. The company offers turbines; clinical micromotors; contra-angles; and built-in, mobile dentistry, oral hygiene, endodontic, surgical, dental laboratory, and hygiene and maintenance products. It also offers motor spindles, and micro gridlers and tools. The company serves automotive, micromechanics, electronics, medical, die/mold, aerospace, and energy industries. Nakanishi Inc. was founded in 1930 and is headquartered in Kanuma, Japan.
IPO date
Jul 19, 2000
Employees
1,478
Domiciled in
JP
Incorporated in
JP
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 59,692,369 22.64% | 48,671,452 8.50% | |||||||
Cost of revenue | 30,426,000 | 23,254,261 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 29,266,369 | 25,417,191 | |||||||
NOPBT Margin | 49.03% | 52.22% | |||||||
Operating Taxes | 5,969,765 | 4,823,920 | |||||||
Tax Rate | 20.40% | 18.98% | |||||||
NOPAT | 23,296,604 | 20,593,271 | |||||||
Net income | 22,835,745 83.10% | 12,471,540 23.45% | |||||||
Dividends | (4,082,674) | (3,607,380) | |||||||
Dividend yield | 2.02% | 1.64% | |||||||
Proceeds from repurchase of equity | (2,999,804) | (2,500,140) | |||||||
BB yield | 1.48% | 1.14% | |||||||
Debt | |||||||||
Debt current | 11,489,268 | 121,843 | |||||||
Long-term debt | 179,370 | 358,957 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 748,054 | 345,842 | |||||||
Net debt | (29,697,228) | (49,264,572) | |||||||
Cash flow | |||||||||
Cash from operating activities | 8,549,399 | 7,764,417 | |||||||
CAPEX | (5,952,740) | (3,984,241) | |||||||
Cash from investing activities | (19,149,217) | (6,314,202) | |||||||
Cash from financing activities | 3,406,227 | (6,107,521) | |||||||
FCF | 6,862,093 | 13,863,528 | |||||||
Balance | |||||||||
Cash | 32,645,313 | 36,179,384 | |||||||
Long term investments | 8,720,553 | 13,565,988 | |||||||
Excess cash | 38,381,248 | 47,311,799 | |||||||
Stockholders' equity | 113,225,164 | 99,136,115 | |||||||
Invested Capital | 87,235,809 | 41,772,710 | |||||||
ROIC | 36.12% | 56.13% | |||||||
ROCE | 22.39% | 28.35% | |||||||
EV | |||||||||
Common stock shares outstanding | 85,434 | 85,945 | |||||||
Price | 2,371.00 -7.27% | 2,557.00 20.73% | |||||||
Market cap | 202,564,377 -7.83% | 219,762,229 19.62% | |||||||
EV | 172,877,452 | 170,504,084 | |||||||
EBITDA | 32,745,139 | 27,521,617 | |||||||
EV/EBITDA | 5.28 | 6.20 | |||||||
Interest | 13,268 | 2,761 | |||||||
Interest/NOPBT | 0.05% | 0.01% |